SODIUM POLYSTYRENE SULFONATE
SODIUM POLYSTYRENE SULFONATE is one of 8,063 medications in the MedPlain dataset. Key details — Brand name: SODIUM POLYSTYRENE SULFONATE; Generic name: SODIUM POLYSTYRENE SULFONATE; Drug class: Potassium Binder [EPC].
| Brand name | SODIUM POLYSTYRENE SULFONATE |
|---|---|
| Generic name | SODIUM POLYSTYRENE SULFONATE |
| Drug class | Potassium Binder [EPC] |
| Manufacturer | Bryant Ranch Prepack |
| Used for | 1 INDICATIONS AND USAGE Sodium polystyrene sulfonate for suspension is indicated for the treatment of hyperkalemia. Limitation of Use : Sodium polystyrene sulfonate for suspension should not be used as an emergency treatment for life-threatening hyperkalemia because of its delayed onset of action [see Clinical Pharmacology (12.2) ] Sodium polystyrene sulfonate for suspension is a potassium binder indicated for the treatment of hyperkalemia ( 1 ). Limitation of Use : Sodium polystyrene sulfonate for suspension should not be used an emergency treatment for life threatening hyperkalemia because of its delayed onset of action ( 1 ). |
| Dosage | 2 DOSAGE AND ADMINISTRATION Oral : The average total daily adult dose of sodium polystyrene sulfonate is 15 g to 60 g, administered as a 15-g dose (four level teaspoons), one to four times daily ( 2.1 ). Rectal : The average adult dose is 30 g to 50 g every six hours ( 2.1 ). 2.1 General Information Administer sodium polystyrene sulfonate at least 3 hours before or 3 hours after other oral medications. Patients with gastroparesis may require a 6 hour separation [see Warnings and Precautions(5.5 |
| Active ingredient(s) | SODIUM POLYSTYRENE SULFONATE |
| Route | ORAL |
| Official label | https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=03a0b525-5e48-4e76-b1fa-700eab10d20a |